03/03/2026
A distinct diabetes category known as Type 3c diabetes mellitus (T3cDM) is increasingly emphasized in modern clinical guidance as a separate form of diabetes that happens because the pancreas is damaged. It is also commonly described as pancreatogenic diabetes or diabetes of the exocrine pancreas.
Unlike Type 1 diabetes, which is driven by an autoimmune attack on insulin-producing cells, and unlike Type 2 diabetes, which is strongly linked to insulin resistance, Type 3c starts with pancreatic disease or injury. Common triggers include chronic pancreatitis, cystic fibrosis, pancreatic cancer, and pancreatic surgery that removes part or all of the pancreas.
What makes Type 3c especially important is that the pancreas has two major jobs: it helps control blood sugar (endocrine function) and it produces digestive enzymes (exocrine function). In Type 3c, both systems can be affected, meaning some patients face glucose instability along with digestion and nutrient-absorption problems.
Research and clinical reporting repeatedly highlight that Type 3c is frequently misdiagnosed as Type 2 diabetes, which can lead to treatment plans that do not fully match the underlying problem. A large UK primary-care analysis reported that Type 3c is commonly misclassified as Type 2.
Estimates from medical literature suggest Type 3c may represent roughly 5% to 10% of diabetes cases in Western populations, which is substantial for a condition many clinicians still under-recognize in routine practice.
Because of the “double hit” to the pancreas, management may involve more than standard glucose control. Many patients need insulin for blood sugar regulation, and some also require pancreatic enzyme replacement therapy to support digestion, depending on how much exocrine function has been lost.
There is also an ongoing, separate scientific discussion around the phrase “Type 3 diabetes” as a research term describing insulin resistance in the brain, explored in relation to Alzheimer’s disease. This is discussed in neuroscience literature, but it is not the same as Type 3c and is not universally adopted as a formal clinical diabetes subtype.
